Immunic, Inc.
IMUXNasdaqCIK 1280776HealthcareFiscal year ends Dec 31
Reports and events: 272 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1121:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193805-26-001219 |
| 2026-09-0913:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-001196 |
| 2026-08-1111:05 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-001071 |
| 2026-08-1110:59 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001280776-26-000018 |
| 2026-07-1412:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000966 |
| 2026-07-0620:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193805-26-000916 |
| 2026-06-2920:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193805-26-000882 |
| 2026-05-2920:33 ET | DEF 14A | Proxy statementPeriod 2026-06-29 | 0001193805-26-000719 |
| 2026-05-2811:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000703 |
| 2026-05-2711:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000696 |
| 2026-05-1911:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000645 |
| 2026-05-1311:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-26-000593 |
| 2026-05-1310:36 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001280776-26-000010 |
| 2026-04-2811:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000516 |
| 2026-04-2312:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-26-000495 |
| 2026-04-2220:56 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193805-26-000493 |
| 2026-04-1420:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001193805-26-000461 |
| 2026-04-1020:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193805-26-000437 |
| 2026-04-0111:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-26-000382 |
| 2026-03-3110:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-26-000370 |
| 2026-03-0221:30 ET | DEF 14A | Proxy statementPeriod 2026-04-14 | 0001193805-26-000201 |
| 2026-02-2612:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001280776-26-000005 |
| 2026-02-2612:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-26-000181 |
| 2026-02-2023:59 ET | SCHEDULE 13D | Ownership report, active investor | 0000921895-26-000531 |
| 2026-02-1312:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-26-000129 |
| 2026-01-0621:05 ET | 8-K | 3.01 Delisting notice | 0001193805-26-000011 |
| 2026-01-0522:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193805-26-000007 |
| 2025-11-1312:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193805-25-001570 |
| 2025-11-1312:17 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001280776-25-000017 |
| 2025-09-2511:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-001357 |
| 2025-08-0710:58 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001280776-25-000012 |
| 2025-08-0710:36 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-001164 |
| 2025-07-1121:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193805-25-001008 |
| 2025-06-2721:15 ET | 8-K | 3.01 Delisting notice | 0001193805-25-000943 |
| 2025-06-0420:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193805-25-000787 |
| 2025-05-3020:44 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-25-000757 |
| 2025-05-2820:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-000730 |
| 2025-05-1520:08 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001280776-25-000008 |
| 2025-04-3011:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-000582 |
| 2025-04-2221:15 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0001193805-25-000541 |
| 2025-04-0921:26 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193805-25-000454 |
| 2025-03-3113:09 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001280776-25-000005 |
| 2025-02-2012:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-000212 |
| 2025-01-1313:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-25-000038 |
| 2024-12-1821:36 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193805-24-001496 |
| 2024-11-0712:04 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001280776-24-000018 |
| 2024-11-0711:45 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-24-001316 |
| 2024-10-2210:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-24-001257 |
| 2024-09-1020:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193805-24-001102 |
| 2024-09-0312:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193805-24-001079 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.